Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of metformin in tumor metabolism in
patients with head and neck cancer by evaluating metformin's ability to decrease TOMM20
expression in squamous carcinoma cells and decrease MCT4 expression in fibroblasts.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University